Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
M S AaproT E Moon

Abstract

Nausea and vomiting remain common and debilitating side effects of therapy with many anticancer drugs. Recent reports have shown that both metoclopramide and dexamethasone are effective drugs for the treatment of severe nausea and vomiting caused by cis-platinum. A double-blind crossover study comparing the antiemetic properties of high-dose oral and intravenous regimens of metoclopramide and dexamethasone in outpatients was carried out. Standardized patient questionnaires and interviews were used to evaluate response. Dexamethasone and metoclopramide protected against more than five episodes of emesis in 48% and 40% of patients, respectively. Nausea persisted for less than six hours in 45% of patients on dexamethasone and in 37% on metoclopramide. The antiemetic efficacy of both regimens was retained through repeated courses of chemotherapy. Side effects were minimal with dexamethasone; however, 33% of patients experienced unacceptable extrapyramidal side effects to metoclopramide. Patient preference was significantly in favor of dexamethasone: 70% of patients chose to continue dexamethasone compared to 22% who preferred metoclopramide and 8% who chose other antiemetics. Dexamethasone was the preferred antiemetic in this patie...Continue Reading

Citations

Mar 22, 1990·The New England Journal of Medicine·L X CubedduA L Finn
Nov 1, 1993·Investigational New Drugs·M Aapro
Mar 17, 1999·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·V RajeevaL K Dhaliwal
Oct 24, 2003·International Anesthesiology Clinics·Ashraf S Habib, Tong J Gan
Feb 6, 2007·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Yoshitaka Fujii, Masahiro Nakayama
May 6, 2019·Cancers·Samantha Kah Ling OngAnupam Bishayee
Dec 1, 1984·Cancer·H J Eyre, J H Ward
Jan 1, 1988·Psychopharmacology·S Revusky, G M Martin
May 1, 1986·Pharmacotherapy·R J Cersosimo, D D Karp
Apr 15, 1988·Cancer·K S Sridhar, E Donnelly
Oct 3, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P IoannidisJ Lau
Sep 29, 2007·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Y Fujii, M Nakayama
Aug 3, 2011·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Joanna R Schwartz
Apr 28, 2018·Journal of Pediatric Hematology/oncology·Edric Paw Cho SingL Lee Dupuis
Sep 8, 2006·Critical Care Medicine·Rasha S BondokAhmed M Abd Elmaksoud
Jan 1, 1992·Cancer Investigation·K S SridharV Cairns
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J GrallaD G Pfister
Jan 1, 1989·Cancer Investigation·F C StiefelJ C Holland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.